| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_091948196f6e8cd318cea821e4222779 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2027
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-205
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2063 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-727 |
| filingDate |
2010-01-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3a8c65887b624007ce18a2f2e2109e15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_990890d8fd52eb56e9c6f1b071ac8628 |
| publicationDate |
2011-12-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-2391352-A1 |
| titleOfInvention |
Pharmaceutical forms for the release of active compounds |
| abstract |
Pharmaceutical form comprising a glycosaminoglycan and a compound presenting independent or dependent pH quaternary ammonium groups, wherein the proportion of ammonium groups in the pharmaceutical form is between 0.01-2.0 μmol ammonium/mg pharmaceutical form, the proportion of glycosaminoglycan in the pharmaceutical form is between 15 % to 50% w/w, and the pharmaceutical form presents a humidity percentage (w/w) lower than 10%. Pharmaceutical formulation comprising said pharmaceutical form, and their use for the manufacture of a medicament. |
| priorityDate |
2009-01-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |